Skip Ribbon Commands
Skip to main content

Limitations of Antiarrhythmic Drugs in the Treatment of Atrial Fibrillation

12 Nov 2020

Antiarrhythmic drug (AAD) therapy aims to restore and maintain sinus rhythm in patients with atrial fibrillation (AF). They remain the main therapeutic agents to restore and maintain sinus rhythm in patients with AF. There are still questions on the efficacy, tolerability and safety of these drugs. This lecture will review the mechanism of actions of AADs, its efficacy and safety in treatment of patients with atrial fibrillation. Case based discussion will be conducted to highlight AAD considerations in the management of patients with different clinical scenarios.

After the lecture, the participants will be able to gain an understanding on:

  • Rhythm control measures in AF
  • AAD and its efficacy on restoring and maintain sinus rhythm
  • Limitations and side effects of AAD

Click here for more lecture details.

To register, scan the QR code or click on the web link. Registration closes on 29 October 2020, Thursday.


Upon registration, participants agreed to the following PGAHI Terms & Conditions.

Lecture Details

12 November 2020, Thursday

6.30 pm - 7.30 pm

60 minutes


Zoom Cloud Meetings


Registration Closing Date:
29 October 2020, Thursday

Target Audience:

Zoom Capacity: 500

This lecture will be conducted via Zoom Cloud Meetings app. For ease of accessing the lecture, please download/update Zoom Cloud Meetings app. Details of the lecture meeting link will be sent to the successful registrants nearer the lecture date.